Standard Biotools (LAB) Change in Accured Expenses (2010 - 2026)

Standard Biotools (LAB) has 17 years of Change in Accured Expenses data on file, last reported at $1000.0 in Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 99.03% year-over-year to $1000.0 in Q1 2026; TTM through Mar 2026 was $10.3 million, a 749.87% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 1170.8% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $1000.0, down from $98000.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for LAB reached as high as $10.1 million in Q3 2025 and fell as low as -$9.4 million in Q3 2022.
• Historically, Change in Accured Expenses has averaged $1.3 million across 5 years, with a median of $505000.0 in 2023.
• On a YoY basis, Change in Accured Expenses climbed as much as 1520.78% in 2024 and fell as far as 1473.86% in 2024.
• Year by year, Change in Accured Expenses stood at $9.9 million in 2022, then sank by 92.57% to $735000.0 in 2023, then sank by 458.5% to -$2.6 million in 2024, then jumped by 103.72% to $98000.0 in 2025, then tumbled by 98.98% to $1000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $1000.0 in Q1 2026, $98000.0 in Q4 2025, and $10.1 million in Q3 2025.